Meden A, Knez D, Brazzolotto X, Modeste F, Perdih A, Pislar A, Zorman M, Denic M, Pajk S, Nachon F, Gobec S (2022) <br />Pseudo-irreversible butyrylcholinesterase inhibitors: SAR, kinetic, computational, and crystallographic study of the N-dialkyl O-arylcarbamate warhead<br /><i>Chemrxiv</i> <br /><br />Meden A, Knez D, Brazzolotto X, Modeste F, Perdih A, Pislar A, Zorman M, Zorovic M, Denic M, Pajk S, Zivin M, Nachon F, Gobec S (2022) <br />Pseudo-irreversible butyrylcholinesterase inhibitors: Structure-activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead<br /><i>Eur Journal of Medicinal Chemistry</i> <b>247</b>: 115048<br /><br />Loi EM, Weiss M, Pajk S, Gobec M, Tomai T, Pieters RJ, Anderluh M (2020) <br />Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition<br /><i>Molecules</i> <b>25</b>: <br /><br />Pajk S, Knez D, Kosak U, Zorovic M, Brazzolotto X, Coquelle N, Nachon F, Colletier JP, Zivin M, Stojan J, Gobec S (2020) <br />Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes<br /><i>J Enzyme Inhib Med Chem</i> <b>35</b>: 498<br /><br />